CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing early cancer detection methods through the identification of specific biomarkers in serum. By utilizing advanced glycopeptide microarray technology, it aims to create diagnostic tools for various cancers, enhancing the potential for timely treatment.
Early detection accomplished through an efficient screening programme remains the most promising approach to improve the long-term survival of cancer patients.
Therefore there is a pressing need for the development of biomarkers, which detect the early changes for cancers where clinical symptoms only appear when the cancer has progressed, and treatment is ineffective.
Our proposal, which addresses this problem at the European level, combines two unique features: i) large unique collections of se…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Denmark, Kobenhavn
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
France, Illkirch-Graffenstaden
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
LONDON
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
KLINIKUM DER UNIVERSITAET ZU KOELN
Germany, Koeln
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
